A commentary published in Brain Medicine by Drs. Julio Licinio and Ma-Li Wong examines groundbreaking research identifying adenosine signaling as the convergent mechanism underlying rapid-acting ...

The Commentary in Brain Medicine titled "Adenosine as the Metabolic Common Path of Rapid Antidepressant Action: The Coffee Paradox," is freely available via Open Access on 11 November 2025 in Brain ...

Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic dissection of rapid antidepressant action identifies adenosine ...

Off-label ketamine is being increasingly used in clinical practice for treatment-resistant depression. Serial infusions of ketamine were no better than midazolam infusions for hospitalized patients ...

Ketamine isn’t effective in treating depression, new clinical trial results indicate Ketamine did not provide any extra benefit among people with depression The placebo effect might explain why ...

An important study published in JAMA Psychiatry (2025) challenges some of the most popular narratives about ketamine’s effectiveness as a rapid antidepressant, underscoring the crucial role of context ...

ATLANTA (WANF/Gray News) - More than 160 pounds of ketamine were seized from the Hartsfield-Jackson Atlanta International Airport, according to Customs and Border Protection officers. On Oct. 11, ...

The mother of a young woman who spent months in excruciating pain before her death has issued an urgent warning about the dangers of ketamine. Beth Ashton, 25, weighed less than her four-year-old ...

Treatment completion was high (86.1%), with patients completing 5 or more infusions, with no adverse events reported. HealthDay News — Low-dose ketamine for chronic refractory pain shows therapeutic ...

Findings from a randomised and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit for ketamine when added onto standard care for ...